Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The biggest development in weight-loss medicine since bariatric surgery ... Some of these access issues were alleviated when ...

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more ...

“Weight Loss Outcomes Associated with Semaglutide ... author of the popular graphics blog Compound Interest To see more of Brunning’s work, go to compoundchem.com. To see all of C&EN’s ...

Besides diabetes, obesity is a major risk factor for hypertension and heart disease, creating what can only be described as a ...

A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...

High demand and supply shortages of weight loss drugs have presented opportunities for counterfeit drugs to enter the market.

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...